Approved for YUTREPIA (treprostinil) inhalation powder is a prostacyclin analogue indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability.. The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation. Side effects, costs, interactions,…
Loading full data from Know Your Drugs Institute…